all
bombay times print stories are available on
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010.
.
.